Experience in a short-term trial with 4-Aminopyridine in cerebellar ataxia

Inventory of Non-Ataxia Signs (INAS): Validation of a New Clinical Assessment Instrument

(2012) H. Jacobi et al.   CEREBELLUM

4-Aminopyridine and cerebellar gait: a retrospective case series

(2012) Roman Schniepp et al.   JOURNAL OF NEUROLOGY

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3

(2012) T. A. Zesiewicz et al.   NEUROLOGY

4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation

(2011) Roman Schniepp et al.   JOURNAL OF NEUROLOGY

Aminopyridines Correct Early Dysfunction and Delay Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1

(2011) R. Hourez et al.   JOURNAL OF NEUROSCIENCE

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

(2011) M. Strupp et al.   NEUROLOGY

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

SCA Functional Index: A useful compound performance measure for spinocerebellar ataxia

(2008) T. Schmitz-Hubsch et al.   NEUROLOGY